NCT02204683View on ClinicalTrials.gov

Pharmacokinetic Study of Intravitreal Aflibercept Injection in Eyes With Wet Age-related Macular Degeneration

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

September 5, 2014

Primary Completion Date

December 14, 2016

Study Completion Date

December 14, 2016

Conditions
Neovascular Macular Degeneration
Interventions
DRUG

Aflibercept

Intravitreal aflibercept

Trial Locations (1)

68105

University of Nebraska Medical Center, Truhlsen Eye Institute, Omaha

All Listed Sponsors
collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

University of Nebraska

OTHER

NCT02204683 - Pharmacokinetic Study of Intravitreal Aflibercept Injection in Eyes With Wet Age-related Macular Degeneration | Biotech Hunter | Biotech Hunter